Literature DB >> 8291203

Increased levels of tumor necrosis factor and interleukin 1 in bronchoalveolar lavage fluids from pigs infected with Mycoplasma hyopneumoniae.

T Asai1, M Okada, M Ono, T Irisawa, Y Mori, Y Yokomizo, S Sato.   

Abstract

We examined the levels of tumor necrosis factor (TNF)-alpha and interleukin-1 (IL-1) in bronchoalveolar lavage fluids (BALF) from pigs experimentally infected with Mycoplasma hyopneumoniae using biological assays with WEHI-164 cells and D10.G4.1 cells, respectively. Increased TNF-alpha and IL-1 in BALF were found in infected pigs with gross and/or microscopic lesions. A time-course study suggested TNF-alpha and IL-1 to be persistently elevated in infected pigs. Their presence in BALF would thus appear to be associated with the development of pneumonic lesions in M. hyopneumoniae infected pigs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8291203     DOI: 10.1016/0165-2427(93)90085-i

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  13 in total

1.  Mycoplasma hyopneumoniae induces pro-inflammatory cytokine and nitric oxide production through NFκB and MAPK pathways in RAW264.7 cells.

Authors:  Mi-Hyun Hwang; Dereje Damte; Joong-Su Lee; Elias Gebru; Zhi-Qiang Chang; Henrique Cheng; Byeong-Yeal Jung; Man-Hee Rhee; Seung-Chun Park
Journal:  Vet Res Commun       Date:  2010-11-23       Impact factor: 2.459

2.  The Hsp72 response in peri-parturient dairy cows: relationships with metabolic and immunological parameters.

Authors:  Elisabetta Catalani; Massimo Amadori; Andrea Vitali; Umberto Bernabucci; Alessandro Nardone; Nicola Lacetera
Journal:  Cell Stress Chaperones       Date:  2010-03-28       Impact factor: 3.667

3.  Increased production of proinflammatory cytokines following infection with porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae.

Authors:  Roongroje Thanawongnuwech; Brad Thacker; Patrick Halbur; Eileen L Thacker
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

Review 4.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

5.  IPEC-J2 cells as reporter system of the anti-inflammatory control actions of interferon-alpha.

Authors:  Elisabetta Razzuoli; Riccardo Villa; Massimo Amadori
Journal:  J Interferon Cytokine Res       Date:  2013-06-18       Impact factor: 2.607

6.  Investigating the role of free-ranging wild boar (Sus scrofa) in the re-emergence of enzootic pneumonia in domestic pig herds: a pathological, prevalence and risk-factor study.

Authors:  Mainity Batista Linhares; Luc Belloy; Francesco C Origgi; Isabel Lechner; Helmut Segner; Marie-Pierre Ryser-Degiorgis
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

7.  Induction of mycoplasmal pneumonia in experimentally infected pigs by means of different inoculation routes.

Authors:  Beatriz Garcia-Morante; Joaquim Segalés; Sergio López-Soria; Ana Pérez de Rozas; Henrike Maiti; Teresa Coll; Marina Sibila
Journal:  Vet Res       Date:  2016-05-09       Impact factor: 3.683

8.  Expression Dynamics of Innate Immunity in Influenza Virus-Infected Swine.

Authors:  María Montoya; Emanuela Foni; Alicia Solórzano; Elisabetta Razzuoli; Massimiliano Baratelli; Dania Bilato; Lorena Córdoba; Maria Angeles Martín Del Burgo; Jorge Martinez; Pamela Martinez-Orellana; Chiara Chiapponi; David S Perlin; Gustavo Del Real; Massimo Amadori
Journal:  Front Vet Sci       Date:  2017-04-21

Review 9.  Concurrent infections are important for expression of porcine circovirus associated disease.

Authors:  Tanja Opriessnig; Patrick G Halbur
Journal:  Virus Res       Date:  2011-09-16       Impact factor: 3.303

10.  Efficacy of one dose vaccination against experimental infection with two Mycoplasma hyopneumoniae strains.

Authors:  Annelies Michiels; Ioannis Arsenakis; Filip Boyen; Roman Krejci; Freddy Haesebrouck; Dominiek Maes
Journal:  BMC Vet Res       Date:  2017-08-29       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.